/L, respectively) (all P < 0.01), (B) The red blood cells (RBC) counts and hemoglobin (Hb) levels of NHD13 mice ((7.729 ± 0.181) × 10 12 /L and (109.8 ± 2.3) g/L, respectively) were lower than those of WT mice ((9.285 ± 0.239) × 10 12 /L and (127.4 ± 3.4) g/L, respectively) (both P < 0.01). The red cell distribution width (RDW) of NHD13 mice (13.72 ± 0.07%) was higher than that of WT mice (13.34 ± 0.08%, P < 0.01). (C) The PLT counts of NHD13 mice ((323.3 ± 23.0) × 10 9 /L) were lower than that of WT mice ((484.9 ± 19.5) × 10 9 /L, P < 0.01). The platelet distribution width (PDW) of NHD13 mice (14.64 ± 0.21%) was higher than that of WT mice (12.96 ± 0.14%, P < 0.01).
Supplementary Figure 3:
Peripheral blood samples from the angular vein and bone marrow samples from the femur of mice were spotted onto the smears. NHD13 mice had cytopenia and dysplasis observed through peripheral blood and BM smears.
(A) Normal blood smear of WT mouse, (B) cytopenia in blood smear of NHD13 mouse, (C) bi-nucleated erythrocyte in blood smear of NHD13 mouse, (D) ringed nucleated neutrophil in blood smear of NHD13 mouse, (E-F) erythroblastic island in BM smear of NHD13 mouse (Wright stain, 10 × 100 visual field).
Supplementary Figure 4: (A)
The proportion of Tfh and PD-1 expression on Tfh in peripheral blood from MDS patients and normal controls were tested by FCM. All samples were stained with CXCR5-APC, CD4-FITC, PD1-PE and the mouse isotype controls (BD, USA). Finally, 20000 cells were acquired on a FACS-Calibur flow cytometry (BD Biosciences, USA) and analyzed by CellQuest software version 3.1.(B) The proportion of Tfh from MDS patients (3.65 ± 1.72%) was lower than that of normal controls (12.59 ± 1.39%, P < 0.01). (C)The PD-1 expression on Tfh from MDS patients (22.20 ± 2.56%) was higher than that of normal controls (5.44 ± 1.45%, P < 0.01).
